During this week two interesting lectures about Industrial Biocatalysis and Biorefineries will take place at UAM facilities and Dr. Pablo Domínguez (CEO & Founder of SUSMOM) will attend as guest speaker. The CEO, and CarbaZyme's participant, is going to share with a wide range of students he's broad knowledge in the field, as well as, he is going to give the attendees an overview of the CarbaZymes project. 

Take note of the dates and download the complete programme here.

Title of the lecture: “Industrial Biocatalysis: Some myths dispelled over successful case studies”

Date: 23.11.16 15:30 hrs.
Venue: Faculty of Sciences, UAM Campus, Cantoblanco. Room: 00.307

Abstract: Biocatalysis has gained a space on industrial synthetic chemistry, with several successful cases already being run at commercial level. In this lecture different enzymatic
processes will be described and thoroughly discussed, spanning from proof-of-concept to industrially-sound reaction conditions. Among other enzymes, lyases – catalyzing C-C bond
forming reactions – will play a core role, given their current and future importance at industrial level. The H2020 funded project CarbaZymes – with the goal of boosting lyases to a further
important level at industry – will be presented during the course of the lecture as well.

 

Title of the lecture: “Biorefineries: From an innovative idea towards (commercial?) development”

Date: 23.11.16 16:30 hrs.
Venue: Faculty of Sciences, UAM Campus, Cantoblanco. Room: 00.307

Abstract: It is presently acknowledged that petroleum resources should be replaced by biobased materials in the coming future, being processed and valorized within the so-called
biorefineries. This paradigm change poses, however, considerable challenges, being petroleum refineries fully optimized and closely integrated, decreasing processing costs to a minimum. In
this lecture, a novel biorefinery concept developed at the university will be shown as case study, with emphasis on options for its potential commercialization. In this way, steps from
academic research (proof-of-concept, patent optimization) to capital raising and set-up of a spin-off will be discussed. The H2020 funded project CarbaZymes – with the goal of taking
biocatalytic processes to a further important level at industry – will be presented during the course of the lecture as well.

Go to top